Playback speed
10 seconds
Lymphoma Immunotherapy: Monoclonal Antibodies and Mechanism of Action, Antibody-Drug Conjugates, Immune Checkpoint Inhibitors, Immune-related Adverse Effects, Allogeneic HTC, T-cell Immunotherapy
By
2018 Pan Pacific Lymphoma Conference
FEATURING
Laura Zitella
By
2018 Pan Pacific Lymphoma Conference
FEATURING
Laura Zitella
149 views
August 15, 2018
Login to view comments.
Click here to Login